mstevens@cooley.com
Dr. Matthew Stevens’s practice focuses on drafting and prosecuting domestic and international patent applications with an emphasis in the fields of small-molecule therapeutics, drug discovery, and biotechnology.
Download full bio
Neurocrine Partners With Takeda to Address Psychiatric Disorders
Vaxcyte - $288 Million IPO
Intellectual Property
Life Sciences
Patent Counseling & Prosecution
Patent Counseling & Prosecution – Life Sciences
Chemistry
Science policy
Cooking and baking
Wine
LGBTQ advocacy
Stanford Medical SchoolPostdoctoral Research Fellow, 2019
Stanford UniversityPhD, Chemistry2017
University of Massachusetts - AmherstBS, Chemistrysumma cum laude, 2012
Neurocrine Partners With Takeda to Address Psychiatric Disorders June 29, 2020
American Chemical Society
American Association for Advancement of Science
+1 650 843 5306
Locations